Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center

被引:3
|
作者
Stevens, Ryan W. [1 ]
Wenger, Jay [2 ]
Bulkow, Lisa [2 ]
Bruce, Michael G. [2 ]
机构
[1] Alaska Native Med Ctr, Anchorage, AK USA
[2] Ctr Dis Control & Prevent CDC, Arctic Invest Program, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Dis, Anchorage, AK 99508 USA
关键词
Streptococcus pneumoniae; invasive pneumococcal disease; antibiotic resistance; antibiotic prescribing; susceptibility; Alaska Natives; Alaska; PNEUMOCOCCAL CONJUGATE VACCINE; SEROTYPE DISTRIBUTION; RESISTANCE PATTERNS; ANTIBIOTIC USE; UNITED-STATES; MACROLIDE; CHILDREN; TRENDS; ERYTHROMYCIN; DISEASE;
D O I
10.3402/ijch.v72i0.22297
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. American Indian/Alaska Native (AI/AN) people suffer substantially higher rates of invasive pneumococcal disease (IPD) than the general US population. We evaluated antimicrobial prescribing data and their association with non-susceptibility in Streptococcus pneumoniae causing IPD in AI/AN people between 1992 and 2009. Methods. Antimicrobial use data were gathered from the electronic patient management system and included all prescriptions dispensed to Alaska Native patients aged 5 years and older from outpatient pharmacies at the Alaska Native Medical Center (ANMC). Antimicrobial susceptibility data were gathered from pneumococcal isolates causing IPD among Anchorage Service Unit AI/AN residents aged 5 years and older. Data were restricted to serotypes not contained in the pneumococcal vaccine (PCV7). Results. Over the study period, overall antimicrobial prescribing increased 59% (285/1,000 persons/year in 1992 to 454/1,000 persons per year in 2009, p < 0.001). Trimethoprim/sulfamethoxazole prescribing increased (43/1,000 persons/year in 1992 to 108/1,000 persons/year in 2009, p < 0.001) and non-susceptibility to trimethoprim/sulfamethoxazole in AI/AN patients >= 5 years of age increased in non-PCV7 serotypes (0-12%, p < 0.05). Similarly, prescribing rates increased for macrolide antibiotics (46/1,000 persons/year in 1992 to 84/1,000 persons/year in 2009, p < 0.05). We observed no statistically significant change over time in erythromycin non-susceptibility among non-PCV7 serotypes in AI/AN patients aged 5 years or greater (0-7%, p = 0.087). Conclusion. Antimicrobial prescribing patterns of some antibiotics in the AI/AN population corresponded to increased antimicrobial resistance in clinical isolates. This study highlights the on-going threat of antimicrobial resistance, the critical importance of judicious prescribing of antibiotics and the potential utility of prescribing data for addressing this issue.
引用
收藏
页数:9
相关论文
共 32 条
  • [1] Global trends in non-susceptibility rates of Streptococcus pneumoniae isolates to ceftriaxone: Data from the antimicrobial testing leadership and surveillance (ATLAS) programme, 2016-21
    Wang, Jiun-Ling
    Lai, Chih-Cheng
    Ko, Wen-Chien
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)
  • [2] Analysis of in vitro Streptococcus pneumoniae non-susceptibility to several antimicrobial agents in a children's hospital in Turkey (1997-2005)
    Gur, D.
    Guciz Dogan, B.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S186 - S186
  • [3] Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae
    Fenoll, A.
    Gimenez, M. J.
    Robledo, O.
    Aguilar, L.
    Tarrago, D.
    Granizo, J. J.
    Martin-Herrero, J. E.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (01) : 75 - 80
  • [4] Non-susceptibility trends of Streptococcus pneumoniae In Southeast-Austria Over A Ten-year Period
    Hoenigl, M.
    Feierl, G.
    Leitner, E.
    Masoud, L.
    Marth, E.
    Grisold, A.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 84 - 84
  • [5] Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae
    A. Fenoll
    M. J. Giménez
    O. Robledo
    L. Aguilar
    D. Tarragó
    J. J. Granizo
    J. E. Martín-Herrero
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 75 - 80
  • [6] Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014
    Hauser, C.
    Kronenberg, A.
    Allemann, A.
    Muehlemann, K.
    Hilty, M.
    EUROSURVEILLANCE, 2016, 21 (21): : 12 - 21
  • [7] Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones
    Fenoll, Asuncion
    Gimenez, Maria-Jose
    Robledo, Olga
    Coronel, Pilar
    Gimeno, Mercedes
    Casal, Julio
    Aguilar, Lorenzo
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (02) : 224 - 226
  • [8] Impact of the revised penicillin susceptibility breakpoints for Streptococcus pneumoniae on antimicrobial resistance rates of meningeal and non-meningeal pneumococcal strains
    Al-Waili, Badria R.
    Al-Thawadi, Sahar
    Al Hajjara, Sami
    ANNALS OF SAUDI MEDICINE, 2013, 33 (02) : 111 - 115
  • [9] FACTORS INFLUENCING PHYSICIAN ANTIMICROBIAL PRESCRIBING AT OUTPATIENT FACILITIES ASSOCIATED WITH BOSTON MEDICAL CENTER.
    Morgan, Jake
    Barlam, Tamar
    Drainoni, Mari-Lynn
    Christiansen, Cindy
    Wetzler, Lee
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 : S161 - S161
  • [10] Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa
    Pemba, L.
    Charalambous, S.
    von Gottberg, A.
    Magadla, B.
    Moloi, V.
    Seabi, O.
    Wasas, A.
    Klugman, K. P.
    Chaisson, R. E.
    Fielding, K.
    Churchyard, G. J.
    Grant, A. D.
    JOURNAL OF INFECTION, 2008, 56 (03) : 171 - 178